The median time from DM onset to subsequent cancer diagnosis throughout the entire follow-up period was shorter for anti-TIF1-Ab-positive compared with anti-TIF1-Ab-negative cases [1.4 years (IQR 0.7–2.5) vs 5.0 (2.5–10.4)]. This evidence concerns the gene TRIM24 and dermatomyositis.